Ranbaxy
Ranbaxy’s subsidiary launches esomeprazole in UK
05 Sep 2011
Ranbaxy in settlement talks with USFDA: Reports
05 May 2011
Merck and Ranbaxy end drug development pact
06 Jan 2011
Atul Sobti quits as Ranbaxy MD & CEO; Arun Sawhney steps in as MD, leaving CEO slot vacant
12 Aug 2010
Atul Sobti, CEO and MD of Ranbaxy has resigned following differences with parent Daiichi Sankyo, about a year after his elevation to the top spot, following the resignation of Malvinder Singh